Nicoderm Cqnicotine
According to the FDA label: Use reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking
30,911 adverse event reports submitted to the FDA (2004–2026)
Top Reported Adverse Events
The most frequently reported events in association with Nicoderm Cq in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.
Show these terms with plain-language definitions
Tap any term below for a plain-language definition.
Drug Ineffective 3,616 reports
A report that the medication did not work as expected for the person taking it. This is a reporting category, not a sign the drug is defective. It simply means someone felt it was not helping their condition.
Full definition in the glossary →Application Site Erythema 3,090 reports
Redness of the skin where a medication was applied, such as under a patch or cream. Erythema means skin redness.
Full definition in the glossary →Application Site Pruritus 2,981 reports
Itching of the skin where a medication was applied, such as under a patch or cream. Pruritus means itching.
Full definition in the glossary →Nausea 2,516 reports
The feeling of sickness in your stomach that often comes before vomiting.
Full definition in the glossary → See all drugs reporting this event →- Nicotine Dependence 2,106 reports
Dizziness 1,592 reports
A feeling of being lightheaded, unsteady, or like the room is spinning.
Full definition in the glossary → See all drugs reporting this event →Malaise 1,347 reports
A general feeling of being unwell or uncomfortable, without a specific symptom.
Full definition in the glossary →Headache 1,332 reports
Pain in the head or upper neck.
Full definition in the glossary → See all drugs reporting this event →Application Site Irritation 1,088 reports
Irritation of the skin where a medication was applied, such as under a patch or cream.
Full definition in the glossary →Application Site Rash 998 reports
A rash on the skin where a medication was applied, such as under a patch or cream.
Full definition in the glossary →Application Site Pain 997 reports
Pain at the spot where a medication was applied, such as under a patch.
Full definition in the glossary →Insomnia 986 reports
Difficulty falling asleep or staying asleep.
Full definition in the glossary → See all drugs reporting this event →Overdose 979 reports
Taking more of a medication than intended or recommended. This can be accidental.
Full definition in the glossary →Vomiting 970 reports
Throwing up the contents of the stomach.
Full definition in the glossary → See all drugs reporting this event →Dyspnoea 950 reports
Shortness of breath or difficulty breathing. Also spelled dyspnea in American English.
Full definition in the glossary → See all drugs reporting this event →
Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.
Who Is Reporting
Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.
By Sex
View reporter sex data as a table
| Sex | Reports |
|---|---|
| Female | 16,740 |
| Male | 9,873 |
| Unknown | 117 |
By Age Group
View age group data as a table
| Age group | Reports |
|---|---|
| 0-17 | 461 |
| 18-34 | 3,271 |
| 35-49 | 4,519 |
| 50-64 | 6,441 |
| 65-74 | 3,057 |
| 75+ | 933 |
This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.
Reported Outcomes
Outcomes recorded in FAERS reports that included Nicoderm Cq. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.
View outcome data as a table
| Outcome | Reports |
|---|---|
| Non-Serious | 18,366 |
| Other Serious | 8,949 |
| Hospitalization | 5,346 |
| Death | 1,724 |
| Life-Threatening | 642 |
| Disability | 369 |
Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.
Report Volume Over Time
Number of FAERS reports received per quarter for Nicoderm Cq. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.
View report trend as a table
| Year | Reports |
|---|---|
| 2004 | 352 |
| 2005 | 3,367 |
| 2006 | 3,412 |
| 2007 | 571 |
| 2008 | 409 |
| 2009 | 524 |
| 2010 | 597 |
| 2011 | 686 |
| 2012 | 718 |
| 2013 | 847 |
| 2014 | 725 |
| 2015 | 2,713 |
| 2016 | 2,032 |
| 2017 | 1,621 |
| 2018 | 2,782 |
| 2019 | 1,904 |
| 2020 | 1,554 |
| 2021 | 1,413 |
| 2022 | 1,105 |
| 2023 | 1,148 |
| 2024 | 1,136 |
| 2025 | 1,080 |
| 2026 (partial) | 215 |
The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.
Medications commonly reported with Nicoderm Cq
In FDA adverse event reports that mention Nicoderm Cq, these medications appeared most often in the same report.
- Nicotine Polacrilex Mini (14,712 reports)
- Nicotine Polarilex (14,712 reports)
- Acetaminophen (2,518 reports)
- Aspirin (1,790 reports)
- Alprazolam (1,773 reports)
This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.
Related Drugs
Other medications with similar adverse event profiles in FDA FAERS reports.
Data Source
This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.
View this data on the FDA website →Data last updated: June 2026